The cost is not the issue. Common garden variety justice is the issue. On behalf of my small holding, let the 249D stay.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025